PHI with Breast cysts
How does this condition affect your private health insurance?
Mammazysten, or breast cysts, are fluid-filled sacs within the breast tissue. They are benign (non-cancerous) and very common, particularly in women between 35 and 50 years old. They can vary in size from microscopic to several centimeters, sometimes feeling like soft grapes or water-filled balloons under the skin. Symptoms may include a palpable lump, tenderness, or pain, especially premenstrually. While often asymptomatic, larger cysts can cause discomfort. Diagnosis typically involves clinical examination, mammography, ultrasound, and sometimes fine-needle aspiration. Although generally harmless, monitoring is sometimes recommended. They are a common component of fibrocystic breast changes and do not typically increase the risk of breast cancer.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Weeks to months; can resolve spontaneously or persist until intervention.
Duration of Illness (Lifetime)
Recurrent or chronic, often associated with hormonal fluctuations over many years.
Cost of Treatment (Initial)
USD 200 - 1500 (diagnostic imaging, consultation, possible aspiration).
Cost of Treatment (Lifetime)
USD 500 - 5000+ (includes monitoring, follow-up visits, potential repeat aspirations over years).
Mortality Rate
Extremely low, as breast cysts are benign and not life-threatening.
Risk of Secondary Damages
Moderate (anxiety, discomfort, need for repeat diagnostic procedures).
Probability of Full Recovery
High (most are benign and resolve or are easily managed without long-term consequences).
Underlying Disease Risk
Low; typically an isolated benign condition, though commonly associated with fibrocystic changes.